Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2009
09/17/2009WO2009114677A1 Pyridazine derivatives as factor xia inhibitors
09/17/2009WO2009114180A1 Inhibitors of the bmp signaling pathway
09/17/2009WO2009113085A1 Novel benzimidazole linked pyrrolo[2,1-q[1,4] benzodiazepine hybrids as potential antitumour agents and process for the preparation thereof
09/17/2009WO2009112954A2 Processes for the preparation of bosentan and related compounds using novel intermediates
09/17/2009WO2009112533A1 Substituted triazinylmethyl sulfonamides
09/17/2009WO2009112529A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors
09/17/2009WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
09/17/2009WO2009112490A1 Sulfonamides as zap-70 inhibitors
09/17/2009WO2009112461A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009WO2009080227A3 Pyrazole-carboxamide derivatives as p2y12 antagonists
09/17/2009WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds
09/17/2009US20090233943 New compounds 835
09/17/2009US20090233928 Imidazolo-5-yl-2-anilo-pyrimidines as agents for the inhibition of cell proliferation
09/17/2009US20090233920 Organic compounds
09/17/2009US20090233918 2-(cyclic amino)-pyrimidone derivatives
09/17/2009US20090233908 Nitrogenous heterocyclic compound and medicinal use thereof
09/17/2009US20090233901 Vla-4 inhibitory drug
09/17/2009US20090233896 Inhibitors of checkpoint kinases
09/17/2009CA2719074A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors
09/17/2009CA2718403A1 Inhibitors of the bmp signaling pathway
09/17/2009CA2718241A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
09/17/2009CA2717529A1 Sulfonamides as zap-70 inhibitors
09/16/2009EP2100878A1 Novel method for the production of sulphonylpyrroles as HDAC inhibitors
09/16/2009EP2099787A1 Aminopyrimidines useful as inhibitors of protein kinases
09/16/2009EP2099786A1 Process for preparing a crystalline form of candesartan cilexetil
09/16/2009EP2099785A1 N-cyanoalkylanthranilamides as insecticides
09/16/2009EP2099774A1 Inhibitors of kinase activity
09/16/2009EP2099770A2 Pyridazinones and furan-containing compounds
09/16/2009EP2099769A1 6-oxo.-1, 6-dihydropyrimidin-2-yls in the treatment of proliferative diseases
09/16/2009EP2099767A1 Modulators of glucocorticoid receptor, ap-1, and/or nf- b activity and use thereof
09/16/2009EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists
09/16/2009EP2099747A1 Radiolabelling via fluorination of aziridines
09/16/2009EP2099452A2 Tricarbonyl complexes with tridentate chelators for myocardium imaging
09/16/2009EP1651214B1 Benzimidazole derivatives as mek inhibitors
09/16/2009EP1581488B1 Inhibitors of tace
09/16/2009EP1478364B1 Selective antibacterial agents
09/16/2009CN101535301A Modulators of chemokine receptor activity, crystalline forms and process
09/16/2009CN101535300A IAP BIR domain binding compounds
09/16/2009CN101535299A 5-lipoxygenase-activating protein (FLAP) inhibitors
09/16/2009CN101535298A Substituted 4-imidazoles
09/16/2009CN101535297A Melanocortin receptor agonists
09/16/2009CN101531655A 9-((2-methyl-1H-imidazole-1-group) ethyl)-9H-carbazole and preparation method thereof
09/16/2009CN100540549C Alpha-substituted-2-methyl-5-nitro-diazole-1-alcohol derivative with optical activity
09/16/2009CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof
09/16/2009CN100540547C Inhibitors of histone deacetylase
09/16/2009CN100540538C Large conductance calcium-activated k channel opener
09/15/2009US7589202 Substituted pyrazoles
09/15/2009US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds
09/15/2009US7589199 Substituted piperazines
09/15/2009US7589197 Pyrimidine compounds
09/15/2009US7589116 Biaryl substituted pyrazoles as sodium channel blockers
09/15/2009US7589115 2-[5-[4-(4-amino-pyrimidin-5-yl)-benzyl]-7-(3,5-dichloro-phenyl)-5-methyl-6-oxo-6,7-dihydro-5H-imidazo[1,2- alpha ]imidazole-3-sulfonylamino]-N-(2-hydroxy-ethyl)-propionamide; inhibit interaction of CAMs and Leukointegrins; are metabolized at a rate that is not overly rapid; antiinflammatories
09/15/2009US7589114 Derivatives of [6,7-dihydro-5H-imidazo[1,2-a]imidazole-3-sulfonyl]-azetidine-carboxylic acids, esters and amides
09/15/2009US7589109 4-{[4-({[(2'-OXOSPIRO[CYCLOPENTANE-1,3'-INDOL]-1'(2'H)-YL)CARBONYL]AMINO}METHYL)PIPERIDIN-1-YL]METHYL}TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID; for condition mediated by 5-HT4 agonistic activity; gastroesophageal reflux disease
09/15/2009US7589108 3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-indole hydrochloride for treatment of central nervous system disorders associated with 5-HT serotonin receptors
09/15/2009US7589098 Controlling cell proliferation; side effect reduction ; anticancer agenst
09/15/2009US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds
09/15/2009US7589086 Substituted pyrazolo[3,4-D]pyrimidines as anti-tumor agents
09/15/2009US7589077 such as 5-iodo-O6-5'-cyclo-5,6-dihydro-3'-azido-3'-deoxythymidine for prophylaxis or diagnosis of viral diseases caused by hepatitis virus, herpes viruses such as Epstein-Barr virus
09/15/2009CA2409819C Triazole derivatives
09/15/2009CA2407754C Prodrugs of hiv replication inhibiting pyrimidines
09/15/2009CA2406562C Hiv replication inhibiting pyrimidines and triazines
09/15/2009CA2402390C Process for the preparation of pyrimidone derivatives with antifungal activity
09/15/2009CA2372560C Cyanopyrroles for binding the progesterone receptor
09/15/2009CA2323111C New substituted indolinones, the preparation thereof and their use as pharmaceutical compositions
09/11/2009WO2009111679A2 Process
09/11/2009WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
09/11/2009WO2009111309A1 Pesticides
09/11/2009WO2009111028A1 Aurora kinase inhibitors
09/11/2009WO2009110558A1 Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink
09/11/2009WO2009110557A1 Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink
09/11/2009WO2009110468A1 Potassium channel opener
09/11/2009WO2009109991A2 Novel hydrazide containing tyrosine kinase inhibitors
09/11/2009WO2009109781A2 Polycyclic organic compounds, polarizing elements and method of production thereof
09/11/2009WO2009109388A1 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
09/11/2009WO2009109258A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/11/2009CA2717836A1 Azo pigment composition, process for producing azo pigment composition, dispersion containing azo pigment composition, coloring composition and ink for inkjet recording
09/11/2009CA2717718A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes
09/11/2009CA2717707A1 Azo pigment composition, production process of azo pigment composition, dispersion containing azo pigment composition, coloring composition and ink for inkjet recording
09/11/2009CA2717171A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists
09/11/2009CA2717069A1 Pesticides
09/11/2009CA2716136A1 Hexahydrocyclopentyl[f]indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
09/11/2009CA2714441A1 Crystal forms of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indol-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide and methods for their preparation
09/10/2009US20090227802 Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof
09/10/2009US20090227793 Image-forming material
09/10/2009US20090227791 Active Esters of N-Substituted Piperazine Acetic Acids, Including Isotopically Enriched Versions Thereof
09/10/2009US20090227596 Heteroaryl nitrile derivatives
09/10/2009US20090227594 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
09/10/2009US20090227593 Cyclobutyl amine derivatives
09/10/2009US20090227592 Compounds effecting glucokinase
09/10/2009US20090227587 Pyrimidines as inhibitors of phosphoinositide-3-kinases (PI3K)
09/10/2009US20090227569 Pyrrolidine derivatives
09/10/2009US20090227560 Substituted imidazole compound and use thereof
09/10/2009US20090227558 Amino-derivatives as novel inhibitors of histone deacetylase
09/10/2009US20090227538 N-(Hetero)Aryl Indole Derivatives as Pesticides
09/10/2009US20090226948 Enzyme-based time temperature indicator
09/10/2009US20090226411 Chemical derivatives and their application as antitelomerase agents
09/10/2009US20090224203 bismethylmaleimide containing monomers containing at least one methyl group when cured used to produce a printed circuit board with high heat resistance and excellent mechanical properties.
09/10/2009US20090223627 Photorefractive dendron compound, photorefractive dendrimer compound, method of prereparing the same, photorefractive device using the same, and method of manufacturing the device
09/09/2009EP2098521A1 Crystal forms of N-[2-(diethylamino) ethyl]-5-[fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrolle-3-carboxamide and methods for their prepparation